How is a blighted ovum (anembryonic pregnancy) typically managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Anembryonic Pregnancy (Blighted Ovum)

Anembryonic pregnancy should be managed with one of three options: expectant management, medical management with misoprostol, or surgical management with suction dilation and curettage (D&C), with the choice depending on patient preference, clinical stability, and gestational age. 1

Diagnosis and Terminology

  • The preferred term is "anembryonic pregnancy" rather than "blighted ovum," defined as a gestational sac measuring ≥25 mm without an embryo, or absence of an embryo on serial ultrasound examinations 1
  • Diagnosis is made via transvaginal ultrasound using specific criteria: mean sac diameter ≥25 mm with no embryo, or absence of embryo ≥14 days after visualization of gestational sac 1, 2
  • Quantitative hCG measurements should be used to confirm declining levels and eventual resolution 2

Management Options

1. Expectant Management

  • Involves waiting for spontaneous passage of pregnancy tissue 1
  • Success rates vary depending on gestational age and time from diagnosis 1
  • Appropriate for hemodynamically stable patients who prefer minimal intervention 1

2. Medical Management

  • Recommended for patients who wish to avoid surgery but desire faster resolution than expectant management 1
  • Misoprostol is the medication of choice 1, 2
  • Particularly useful for incomplete miscarriages 2

3. Surgical Management (D&C)

  • Indicated for patients with:
    • Hemodynamic instability
    • Significant bleeding
    • Signs of infection 1
  • Should be performed under ultrasound guidance to reduce risk of uterine perforation 2
  • Uterotonic agents should be administered during and after the procedure to reduce bleeding risk 2

Follow-up and Monitoring

  • Serial hCG monitoring until levels return to non-pregnant state 1, 2
  • Ultrasound evaluation to confirm complete evacuation of products of conception 1, 2
  • Histopathologic examination of tissue is recommended to:
    • Confirm intrauterine pregnancy
    • Rule out gestational trophoblastic disease 1, 2
  • Blood type and Rh status should be assessed, with Rho(D) immunoglobulin administered to Rh-negative women 2

Complications to Monitor

  • Risk of infection increases with time after diagnosis, particularly after 18 hours 1, 3
  • Hemorrhage is a potential complication, especially with incomplete evacuation 1
  • Warning signs requiring immediate intervention include:
    • Fever >100.4°F (38.0°C)
    • Uterine tenderness
    • Purulent vaginal discharge 3

Common Pitfalls to Avoid

  • Using outdated terminology like "blighted ovum" can be hurtful to patients 1
  • Failing to confirm complete evacuation of products of conception can lead to complications 1
  • Overlooking the possibility of heterotopic pregnancy (though rare in spontaneous conceptions) 4
  • Inadequate follow-up after management, which is essential to ensure resolution 1, 2

Special Considerations

  • Advanced maternal age is a risk factor for anembryonic pregnancy 5
  • Low β-HCG levels are associated with increased risk of anembryonic pregnancy 5
  • No specific waiting period is required before attempting pregnancy after management of anembryonic pregnancy, though many clinicians traditionally recommend waiting 1-3 menstrual cycles 6

References

Guideline

Management of Anembryonic Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Miscarriage Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Time-Critical Management of Ruptured Amniotic Fluid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Blighted ovum in subfertile patients undergoing assisted reproductive technology].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2017

Research

Attempting pregnancy after miscarriage and curettage--what is the minimum interval?

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.